You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 706 First-in-human phase 2 clinical trial of multiplex combination intratumoral immunotherapy (MCII) in patients with metastatic solid cancer (Abscopal 5001 trial)

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
706 First-in-human phase 2 clinical trial of multiplex combination intratumoral immunotherapy (MCII) in patients with metastatic solid cancer (Abscopal 5001 trial)

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 202320606
Dec 20236608
Jan 20244308
Feb 20244806
Mar 20244006
Apr 202428012
May 20243005
Jun 20242205
Jul 20242804
Aug 20244605
Sep 20244204
Oct 20242601
Nov 20243204
Dec 20243807
Jan 20253006
Feb 20251404
Mar 20250014
Apr 2025005
May 2025005
Jun 2025106
Total7400121